These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 18930040

  • 1. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C.
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M, Krzewina-Kowalska A, Kubica J, Zbikowska-Gotz M, Dymek G, Piasecki R, Sukiennik A, Grzesk G, Bogdan M, Chojnicki M, Dziedziczko A, Sypniewska G.
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [Abstract] [Full Text] [Related]

  • 3. Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries.
    Kitta Y, Takano H, Nakamura T, Kodama Y, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata JE, Mende A, Kobayashi T, Kugiyama K.
    Int J Cardiol; 2008 Dec 17; 131(1):78-82. PubMed ID: 18180052
    [Abstract] [Full Text] [Related]

  • 4. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
    Nishimura M, Hashimoto T, Kobayashi H, Yamazaki S, Okino K, Fujita H, Inoue N, Takahashi H, Ono T.
    Nephrol Dial Transplant; 2006 Jun 17; 21(6):1640-7. PubMed ID: 16431887
    [Abstract] [Full Text] [Related]

  • 5. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
    Kitta Y, Nakamura T, Kodama Y, Takano H, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata JE, Ichigi Y, Mende A, Kugiyama K.
    J Am Coll Cardiol; 2005 Aug 16; 46(4):648-55. PubMed ID: 16098430
    [Abstract] [Full Text] [Related]

  • 6. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J, Hudzik B, Romanowski W, Wilczek K, Danikiewicz A, Gasior M, Polonski L, Zubelewicz-Szkodzinska B.
    J Biol Regul Homeost Agents; 2010 Aug 16; 24(2):149-56. PubMed ID: 20487628
    [Abstract] [Full Text] [Related]

  • 7. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M, Takahashi H.
    Rinsho Byori; 2011 Aug 16; 59(8):795-800. PubMed ID: 21942090
    [Abstract] [Full Text] [Related]

  • 8. [Association between plasma adiponectin level and in-stent restenosis after coronary stenting].
    Qin Q, Lu YR, Li Y, Kou L, Feng JP, Chen G, Li CJ, Zhao BR.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Mar 16; 38(3):239-42. PubMed ID: 20450566
    [Abstract] [Full Text] [Related]

  • 9. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T, Takahashi M, Iizuka T, Shirai K.
    J Cardiol; 2006 Aug 16; 48(2):65-73. PubMed ID: 16948449
    [Abstract] [Full Text] [Related]

  • 10. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.
    Chin Med J (Engl); 2013 Mar 16; 126(6):1019-25. PubMed ID: 23506572
    [Abstract] [Full Text] [Related]

  • 11. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY, Qiao SB, Zhang JF, Dong QT, Li JJ.
    Coron Artery Dis; 2012 May 16; 23(3):181-7. PubMed ID: 22336660
    [Abstract] [Full Text] [Related]

  • 12. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S, Asanin M, Trifunovic D, Majkic-Singh N, Miljković A, Ignjatovic S, Mrdovic I, Matic D, Savic L, Ostojic M, Vasiljevic Z.
    Clin Lab; 2012 May 16; 58(11-12):1135-44. PubMed ID: 23289182
    [Abstract] [Full Text] [Related]

  • 13. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
    Katsaros KM, Wiesbauer F, Speidl WS, Kastl SP, Huber K, Zorn G, Niessner A, Glogar D, Maurer G, Wojta J.
    Thromb Haemost; 2011 May 16; 105(5):883-91. PubMed ID: 21359408
    [Abstract] [Full Text] [Related]

  • 14. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R, Aronow WS, Sureddi R, Aleti S, Molavi B, Sachdeva R, Mehta JL.
    Am J Cardiol; 2007 Sep 01; 100(5):777-80. PubMed ID: 17719319
    [Abstract] [Full Text] [Related]

  • 15. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M, Kubica J, Sukiennik A, Zbikowska-Gotz M, Krzewina-Kowalska A, Radomski M, Rychter M, Bialoszynski T, Jablonski M, Demidowicz K, Grzesk G, Bogdan M, Chojnicki M, Grabczewska S, Dziedziczko A.
    Int J Mol Med; 2007 Jan 01; 19(1):187-95. PubMed ID: 17143564
    [Abstract] [Full Text] [Related]

  • 16. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.
    Naruko T, Ueda M, Ehara S, Itoh A, Haze K, Shirai N, Ikura Y, Ohsawa M, Itabe H, Kobayashi Y, Yamagishi H, Yoshiyama M, Yoshikawa J, Becker AE.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):877-83. PubMed ID: 16469945
    [Abstract] [Full Text] [Related]

  • 17. Is inflammation a contributor for coronary stent restenosis?
    Li JJ, Nie SP, Zhang CY, Gao Z, Zheng X, Guo YL.
    Med Hypotheses; 2007 Apr 01; 68(5):945-51. PubMed ID: 17045418
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
    Pleva L, Kusnierova P, Plevova P, Zapletalova J, Karpisek M, Faldynova L, Kovarova P, Kukla P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec 01; 159(4):586-94. PubMed ID: 26365933
    [Abstract] [Full Text] [Related]

  • 19. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
    Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH.
    Clin Chim Acta; 2009 Jul 01; 405(1-2):114-8. PubMed ID: 19397903
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S, Güneri S, Akdeniz B, Ozcan MA, Baris N, Badak O, Kirimli O, Yüksel F.
    Am J Cardiol; 2006 Jan 15; 97(2):198-202. PubMed ID: 16442363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.